XematAdvanced Eye Health Programme
Xemat combines vitamins for eye health and the optic nerve with O-3 Retimax® (DHA free from phytanic acid), Restrol, Fibromatrix, Ginkgo biloba and lutein. Protects against visual deterioration, improves eye function in presbyopia and macular degeneration, and reduces optic nerve inflammation.
FormatWhy choose Xemat
Celavista's most advanced eye health programme to protect the optic nerve, regenerate the retina and combat age-related visual deterioration.
Complete ocular neuroprotection
Xemat is an optic nerve supplement that acts through multiple mechanisms. Patented O-3 Retimax® (DHA free from phytanic acid) accumulates in retinal cells — the first and only DHA used in EMA and FDA clinical trials. NAD+ improves neuronal cellular energy and baicalein provides direct neuroprotection. Essential vitamins for eye health and the optic nerve.
Antioxidant retinal protection
The Retimax® complex combines bilberry anthocyanidins with grape and pine proanthocyanidins, protecting the retina from oxidative stress. Lutein filters harmful radiation whilst zinc maintains retinal function. Restrol improves ocular microcirculation with extended-bioavailability resveratrol that remains active for days.
Ocular vascular regeneration
Fibromatrix protects collagen, elastin and hyaluronic acid in ocular vessels. It is venotonic, anti-oedematous and anti-haemorrhagic. Ginkgo biloba optimises ocular tissue oxygenation whilst Cypen provides cytoprotection. Reduces eye strain and strengthens optic nerve circulation.
Composition of Xemat
19 molecules in their maximum purity and bioavailability, selected after years of scientific research.
| Molecule | Dose per capsule Dose | ||
|---|---|---|---|
|
Vitamin D3
vitamin D3 (cholecalciferol)
|
Bone health | 4000 UI | |
|
Selenium
selenium (Se)
|
Thyroid protection | 220 µg | |
|
NAD+
NAD+ (nicotinamide riboside)
|
Cellular energy | 200 mg | |
|
Zinc
zinc (Zn)
|
Cellular immunity | 25 mg | |
|
Lutein
lutein
|
Macular health | 30 mg | |
|
Alpha-cyperone
alpha-cyperone (Cyperus rotundus)
|
Neuroprotection | 60 mg | |
|
Baicalein
baicalein (Scutellaria baicalensis)
|
Cellular antioxidant | 400 mg | |
|
Bilobalide
bilobalide (Ginkgo biloba)
|
Cerebral flow | 12000 µg | |
|
Ginkgolides
ginkgolides (Ginkgo biloba)
|
Microcirculation | 12000 µg | |
|
Ginkgo biloba
Ginkgo biloba (standardized extract)
|
Cerebral circulation | 400 mg | |
|
Resveratrol
resveratrol
|
Anti-aging | 480 mg | |
|
Anthocyanidins
anthocyanidins
|
Vision & circulation | 70 mg | |
|
Proanthocyanidins
proanthocyanidins (OPC)
|
Vascular protection | 200 mg | |
|
β-escin
β-escin (Aesculus hippocastanum)
|
Vascular health | 80 mg | |
|
Ellagic acid
ellagic acid
|
DNA protection | 130 mg | |
|
EGCG
epigallocatechin gallate (EGCG)
|
Maximum antioxidant | 520 mg | |
|
Hamamelitannin
hamamelitannin (HT)
|
Venous tone | 240 µg | |
|
DHA
docosahexaenoic acid - DHA (Omega 3-Retriacyl)
|
Brain & heart | 1600 mg | |
|
Quercetin
quercetin
|
Natural antihistamine | 400 mg | |
How to take Xemat
Follow these recommendations to get the best results. Dosage may vary according to your individual needs.
Complete standard protocol
Yellow capsules: 2 in the morning and 2 in the evening. Black capsules: 1 in the morning and 1 in the evening. Complete protocol for presbyopia prevention, macular degeneration, glaucoma and retinopathies. The yellow capsules contain antioxidant nutrients and vitamins for eye health, whilst the black ones provide O-3 Retimax® for optimal retinal accumulation.
What our customers say
Frequently asked questions about Xemat
Taking care of yourself today will prevent the symptoms of tomorrow.
At Celavista we have been studying and enhancing solutions from nature for over 30 years. Our philosophy is focused on treating common diseases with unmet needs. We are scientists who study nature with a pure and unprejudiced perspective, which allows us to rediscover the science that lies within it. Our goal is to use its millions of years of experimentation to inform the science of the future and reinvent medicine.

